by David Kent | May 14, 2020
The second post in this series on gene therapy and blood stem cells might give readers a small sense of the absolutely enormous research investment (time, money, people, etc.) required to find a way to expand blood stem cells for therapeutic purposes. Ever since the...
by David Kent | May 6, 2020
As mentioned in the introductory post to this series on blood stem cell gene therapy, several significant issues existed with the first set of clinical trials in the gene therapy world. It became abundantly clear that simply delivering the gene target on its own would...
by David Kent | Apr 30, 2020
Blood stem cells are the fundamental component of regenerative medicine applications involving the blood and immune system. Despite significant efforts and investment, the research community has largely failed to maintain fully functional blood stem cells for...
by David Kent | Apr 21, 2020
Over the coming weeks, I will be writing a series of blog entries on gene therapy using blood stem cells as a base cellular product. In the last few years we have witnessed an incredible return to the headlines for gene therapy now that safer, more accurate tools have...
by Lyla El-Fayomi | Apr 16, 2020
Starting work on a new research project can be overwhelming. This is especially true in the stem cell field, with its complexities and rapid evolution. It is quite easy to get lost while conducting literature searches or looking for specific protocols, making it feel...
by Samantha Yammine | Apr 2, 2020
On most days, scientific discoveries are not cover stories or even top headlines. That hasn’t been the case since COVID-19 hit our collective consciousness. We are being inundated with science news, which would be great under different circumstances. But communicating...
by Jovana Drinjakovic | Mar 26, 2020
Earlier this month, Chinese media reported that doctors in Yunnan cured a patient from coronavirus with a stem cell transplant. But did they really and do stem cells actually hold promise against the new virus wreaking havoc across the world? The global pandemic has...
by Laine Bodnar | Mar 19, 2020
Canada’s strength in regenerative medicine (RM) and cell and gene therapies is a result of efforts that take place from sea to shining sea. Western Canada’s growing RM community significantly increases Canada’s competitiveness on the global playing field through its...
by CCRM Australia | Mar 12, 2020
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here As stem cell therapies move through clinical trials and get closer to...
Comments